2016
DOI: 10.1111/ane.12623
|View full text |Cite
|
Sign up to set email alerts
|

Risk of osteoporotic fractures in multiple sclerosis patients in southwest Finland

Abstract: We observed high prevalence of MS in southwest Finland and confirmed increased age-adjusted comorbid risk for osteoporotic fractures and other low-energy fractures compared with individually matched controls.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
1
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 38 publications
0
9
1
1
Order By: Relevance
“…Our study is retrospective, and the duration of follow‐up was rather short for condition like MS, only 5 years. However, it does show an increasing prevalence of MS compared to the result of the previous study in SwF from 2012 …”
Section: Discussioncontrasting
confidence: 61%
See 3 more Smart Citations
“…Our study is retrospective, and the duration of follow‐up was rather short for condition like MS, only 5 years. However, it does show an increasing prevalence of MS compared to the result of the previous study in SwF from 2012 …”
Section: Discussioncontrasting
confidence: 61%
“…Finland has been known to be a country of high MS risk, and our results support this. The 280/100 000 age‐standardized (ESP) prevalence of MS in SwF is among the highest in the world and has increased significantly during the past four years . Furthermore, the crude incidence rate of 11.7/100 000 is similar to other high‐risk regions in Finland confirming that southwest Finland is a hotspot of multiple sclerosis in Finland.…”
Section: Discussionmentioning
confidence: 75%
See 2 more Smart Citations
“…Finland is a high‐risk multiple sclerosis (MS) region based on regional studies, but nationwide MS prevalence studies have not been performed recently. A national MS register was launched in 2014, which enables systematic follow‐up of incidence and prevalence figures as well as many clinical variables.…”
Section: Introductionmentioning
confidence: 99%